Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,012 | -50,122 | -19,673 | -19,165 | -16,542 |
| Depreciation Amortization | 56 | 192 | 133 | 88 | 45 |
| Income taxes - deferred | N/A | -15,267 | 52 | 52 | N/A |
| Accounts receivable | -16 | N/A | 7 | N/A | N/A |
| Other Working Capital | 468 | 1,679 | -18 | 411 | 427 |
| Other Operating Activity | -538 | 53,201 | 12,222 | 14,524 | 14,511 |
| Operating Cash Flow | $-4,042 | $-10,317 | $-7,277 | $-4,090 | $-1,559 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -339 | -217 | -18 | -5 |
| Other Investing Activity | 19 | 77 | 55 | 37 | 19 |
| Investing Cash Flow | $1 | $-262 | $-162 | $19 | $14 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,007 | 15,885 | 15,882 | 15,882 | 11,832 |
| Financing Cash Flow | $5,007 | $15,885 | $15,882 | $15,882 | $11,832 |
| Beginning Cash Position | 9,276 | 3,970 | 3,970 | 3,970 | 3,970 |
| End Cash Position | 10,242 | 9,276 | 12,413 | 15,781 | 14,257 |
| Net Cash Flow | $966 | $5,306 | $8,443 | $11,811 | $10,287 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,042 | -10,317 | -7,277 | -4,090 | -1,559 |
| Capital Expenditure | -18 | -339 | -217 | -18 | -5 |
| Free Cash Flow | -4,060 | -10,656 | -7,494 | -4,108 | -1,564 |